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EVALUATING FATIGUE AND HOPE IN PEDIATRIC HEMATOPOIETIC STEM
CELL TRANSPLANTATION RECIPIENTS
Bailey, J.R.1, Pavlock, T.1, Germann, J.1,2, Koh, A.1,2, Aquino, V.M.1,2
1Children’s Medical Center Dallas, Dallas, TX; 2University of Texas
Southwestern Medical Center at Dallas, Dallas, TX
Background: Fatigue is a common side effect of chemotherapy, but
is poorly studied in pediatric HSCT recipients. Hope, or goal-di-
rectedness, may be impacted by fatigue. The incidence and severity
of fatigue and its impact on hope warrants investigation.
Patients andMethods: Patients were eligible for enrollment in this
prospective study if they were between the ages of 5-18 years. Pa-
tients unable to read English or otherwise unable to complete the
survey were ineligible. Subjects completed the PedsQL Multidimen-
sional Fatigue Scales(Fatigue QOL) and Children’s Hope Scale. Subjects
were enrolled during a regular follow-up clinic visit and completed
the surveys. The results of the fatigue surveys were then compared
to healthy subjects and oncology patients in a validated sample as re-
ported by Varni et al (Cancer, 2002; 94:2090-2106).
Results: A total of 12 subjects who had HSCT were enrolled, at
a mean of 12 yrs. of age (range of 6-19 yrs). 2 had received autologous
HSCT, 9 had received allogeneic HSCT, and 1 patient received an
auto followed by an allo HSCT. 3 had graft versus host disease at the
time of survey completion. HSCT recipients had an average Total
Fatigue QOL score of 70.2 (range 38.9-91.6) and 8/12 (66%) had
a lower score than the average for healthy subjects. HSCT recipients
had a statistically significant lower average Total FatigueQOL score
(70.2 vs. 80.5, p 5 0.02) and average General Fatigue QOL score
(71.2 vs. 85.3, p 5 0.008), and a trend to a lower average Sleep Fa-
tigue QOL score (63.53 vs. 75, p 5 0.05), when compared with
healthy subjects. There was no statistically significant difference in
average Cognitive Fatigue QOL scores (74.99 vs. 81.14, p 5 0.26).
However, there were no statistically significant differences in average
Fatigue QOL scores in SCT recipients when compared to patients
undergoing chemotherapy. The average hope score was 0.76 (range
of 0.46-1), which corresponds to feeling hopeful ‘‘a lot of the time.’’
There was no statistically significant correlation between Total Fa-
tigue QOL and hope scores (r 5 0.37, p 5 0.1).
Conclusions: Fatigue is more prominent in pediatric HSCT recip-
ients than a healthy population. In this small series, fatigue was not
related to hope. Fatigue experienced byHSCT recipients was similar
to that seen in children receiving chemotherapy. Larger prospective
studies are needed to determine risk factors for fatigue and to develop
interventions to alleviate fatigue in pediatric HSCT recipients.
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PHYSICIAN – NURSE COLLABORATION: ASSESSMENT AND INTERVEN-
TION TO STRENGTHEN THE SPECIALTY BMT TEAM
Skeens, M.A., Taylor, G. Nationwide Children’s Hospital, Columbus, OH
Background: Collaboration is defined as ‘‘individuals with varying
Background and expertise communicating effectively with one an-
other’’ (Tschannen et al 2011). Collaboration has been identified
as a key factor in decreasing errors, improving patient outcomes
and increasing overall nursing satisfaction. One of the five principles
for creating safe systems of care delivery from the Institute of Med-
icine report on medical errors concluded ‘‘healthcare organizations
need to promote team functioning’’. Little empirical evidence exists
related to collaboration and communication within specialty teams
and patient outcomes. The primary aim of this study is to determine
the impact of BMT specialty nursing on collaboration and commu-
nication with MDs and APNs. Secondary aims are to include the
correlation between patient outcomes, nursing satisfaction and col-
laboration scores.
Methods: The Collaboration and Satisfaction about Care Deci-
sions (CSACD) measuring RN/MD collaboration and satisfaction
and the Intensive Care Unit Management Attitudes Questionnaire
(ICUMAQ) were adapted and administered to all BMT MDs,
APNs and RNs. The tools were administered at baseline prior
to any intervention and then at three months. Additional time
points will include 6, 9 and 12 months. Surveys were initially ad-ministered via paper, however 3 month follow-up and future as-
sessments will be administered electronically. In the first three
month period several interventions were instituted to increase col-
laboration and communication. Interventions included; BMT spe-
cialty nursing, ongoing education classes, multidisciplinary retreat,
and a newsletter. In the following three months interventions will
include; evening rounds, RN participation in weekly meetings, de-
briefings, and additional interventions needed based on situational
circumstances.
Conclusion: Baseline and 3 month data is currently being analyzed.
This study aims to test effectiveness of interventions over time to in-
crease communication and collaboration. The goal is to observe an
increase in collaboration scores and correlatively an overall improve-
ment in patient outcomes.
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EDUCATIONAL NEEDS INITIATED BY ALLOGENEIC TRANSPLANT PA-
TIENTS AT TIME OF DISCHARGE
Grant, M.1, Cooke, L.1, Gemmill, R.2 1City of Hope, Duarte, CA; 2Pri-
vate Practice, Burbank, CA
Purpose: Educational needs emerged at the time of discharge for
141 allogeneic transplant patients who were enrolled in an experi-
mental group of an Advanced Practice Nurse (APN) Intervention
study designed to compare quality of life (QOL), functional status,
caregiver issues, mortality and treatment complications between 2
groups.
Methods: The data represents the qualitative analysis of spontane-
ous patient questions following a standardized initial teaching inter-
vention at discharge. The initial intervention was followed by 5
individual sessions with the patient, and caregivers. Content was de-
veloped by experienced transplant nurse and a literature review and
organized by the QOLmodel. Session 1 content included: preparing
for discharge, hygiene, skin management, venous access device are,
clinic routines, signs and symptoms of infection, dehydration pre-
vention and a review of medications. Following this session the
APN provided time for the patients to ask additional questions.
Results: The average age was 49, 73 males and 68 females; most
were Caucasian, 82.3%. The top four diagnoses were Acute Leuke-
mia (55.3%), Myelodysplastic syndrome (17.7%), Non-Hodgkin’s
lymphoma (13.5%), and Chronic Leukemia (10.6%).Matched unre-
lated allogeneic transplant patients were the majority (52.5%), and
most patients also underwent reduced intensity transplant (55.3%).
Examples of questions included diabetes and blood sugar control,
comorbid illnesses, homesickness, worry about pets, caregiver issues,
childcare, marital conflicts, financial concerns, and retelling the story
of the diagnosis and journey.
Conclusions:Hospital discharge is a critical point in the transplant
patient’s trajectory. In addition to standard discharge education,
open discussion revealed individualized and psychosocial topics.
Research Implications: Educational intervention studies need to
provide for requests for patients for additional content beyond stan-
dardized material.
Clinical Implications: Bedside transplant nurses need to have excel-
lent ‘‘educational’’ assessment skills, clinical competence, and flexi-
bility to ‘‘teach in the moment’’ and adapt to patient needs.
Acknowledgement of Funding: NCI RO1 CA 107446.
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COMPARING PEGYLATED AND CONVENTIONAL G-CSF IN THE MOBILISA-
TION OF PBSC IN PATIENTS WITH MYELOMA
Trengrove, A.M.1, Schouten, J.E.2, Fernyhough, L.3 1Canterbury District
Health Board, Christchurch, Canterbury, New Zealand; 2Christchurch,
Canterbury, New Zealand; 3University of Otago, Christchurch, Canter-
bury, New Zealand
Purpose: Since December 2009 in Christchurch Hospital, New
Zealand, the standard Peripheral Blood Stem Cell (PBSC) mobilisa-
tion protocol used for Myeloma patients changed from daily G-CSF
to a single dose of Pegylated G-CSF. This audit compares the out-
comes of the two approaches.
Methods: A retrospective audit of clinical notes was undertaken on
all sequential myeloma patients who had been mobilised with pegy-
latedGCSF. An equal number of sequential myeloma patients mobi-
lised prior to December 2009 using conventional daily GCSF were
